ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Wang, Huan ^a   Yang, Yue Bo ^a   Shen, Hui Min ^a   Gu, Jian ^a   Li, Tian ^a   Li, Xiao Mao ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; BIM PROTEIN; MESSENGER RNA; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BINDING SITE; CELL PROLIFERATION; DOWN REGULATION; HELA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIPHENYL COMPOUNDS; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; NITROPHENOLS; PIPERAZINES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RADIATION; RADIATION TOLERANCE; RNA, MESSENGER; SULFONAMIDES;

EID: 84871419821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052483     Document Type: Article

References (27)

1. Kang MH, Reynolds CP, (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy[J]. Clin Cancer Res 15: 1126-1132.
2. Keuling AM, Andrew SE, Tron VA, (2010) Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA[J]. Pigment Cell Melanoma Res 23(3): 430-440.
3. Will B, Siddiqi T, Jorda MA, Shimamura T, Luptakova K, et al. (2010) Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells[J]. Blood 115(14): 2901-2909.
4. Dasmahapatra G, Lembersky D, Rahmani M, Kramer L, Friedberg J, et al. (2009) Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress[J]. Cancer Biol Ther 8(9): 808-819.
5. Konopleva M, Milella M, Ruvolo P, Watts JC, Ricciardi MR, et al. (2011) MEK inhibition enhances ABT-737-induced leukemia cell apoptosisi via prevention of ERK-activated MCL-1/BIM complex [J]. Theor Appl Genet 122(8): 1517-1536.
6. Subramanian SL, Hull RL, Zraika S, Aston-mourney K, Udayasankar J, et al. (2012) cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets[J]. Diabetologia 55(1): 166-174.
7. Li DD, Wang LL, Deng R, Tang J, Shen Y, et al. (2009) The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cell[J]. Oncogene 28: 886-898.
8. Kerr JF, Winterford CM, Harmon BV, (1994) Apoptosis. Its significance in cancer and cancer therapy[J]. Cancer 73(8): 2013-2026.
9. Pollack M, Leeuwenburgh C, (2001) Apoptosis and Aging: Role of the Mitochondria. [J]. J Gerontol A Biol Sci Med Sci. 56(11): B475-482.
10. Petros AM, Dinges J, Augeri DJ, Baumeister SA, Betebenner DA, et al. (2006) Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis[J]. J Med Chem 49(2): 656-663.
11. Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH, (2011) Emerging Bcl-2 inhibitors for the treatment of cancer[J]. Expert Opin Emerg Drugs 16(1): 59-70.
12. Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, et al. (2007) Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737[J]. J Clin Invest 117(1): 112-121.
13. Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, et al. (2007) Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737[J]. Cancer Res 67(3): 1176-1183.
14. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours[J]. Nature 435(7042): 677-681.
15. Trudel S, Stewart AK, Li Z, Shu Y, Liang SB, et al. (2007) The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan[J]. Clin Cancer Res 13(2 Pt 1): 621-629.
16. Kang MH, Kang YH, Szymanska B, Wilczynska-Kalak U, Sheard MA, et al. (2007) Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo[J]. Blood 110(6): 2057-2066.
17. Sluss HK, Barrett T, Derijard B, Davis RJ, (1994) Signal transduction by tumor necrosis factor mediated by JNK protein kinases[J]. Mol Cell Biol 14(12): 8376-8384.
18. Liu J, Lin A, (2005) Role of JNK activation in apoptosis: a double-edged sword[J]. Cell Res 15(1): 36-42.
19. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH, (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation[J]. J Biol Chem 271(50): 31929-31936.
20. Howard AN, Bridges KA, Meyn RE, Chandra J, (2009) ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress[J]. Cancer Chemother Pharmacol 65(1): 41-54.
21. Lei K, Davis RJ, (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis[J]. Proc Natl Acad Sci U S A 100(5): 2432-2437.
22. Srivastava RK, Sollott SJ, Khan L, Hansford R, Lakatta EG, et al. (1999) Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis[J]. Mol Cell Biol 19(8): 5659-5674.
23. van der Sanden MH, Meems H, Houweling M, Helms JB, Vaandrager AB, (2004) Induction of CCAAT/enhancer-binding protein (C/EBP)-homologous protein/growth arrest and DNA damage-inducible protein 153 expression during inhibition of phosphatidylcholine synthesis is mediated via activation of a C/EBP-activating transcription factor-responsive element[J]. J Biol Chem 279(50): 52007-52015.
24. Yoon S, Choi J, Yoon J, Huh JW, Kim D, (2006) Okadaic acid induces JNK activation, bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons[J]. Neurosci Lett 394(3): 190-195.
25. Watson A, Eilers A, Lallemand D, Kyriaksi J, Rubin LL, et al. (1998) Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons[J]. J Neurosci 18(2): 751-762.
26. Yao H, Tang X, Shao X, Feng L, Wu N, et al. (2007) Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9[J]. Cell Res 17(6): 565-571.
27. Adams JM, Cory S, (2007) The Bcl-2 apoptotic switch in cancer development and therapy [J]. Oncogene 26(9): 1324-1337.